ホルター心電図市場は、予測期間中に6.5%のCAGRで成長し、2025年の4億9,000万米ドルから2030年には7億6,000万米ドルに達すると予想されます。2024年現在、ホルター心電図市場の主要企業には、GE HealthCare(米国)、Koninklijke Philips N.V.(オランダ)、日本光電株式会社(日本)、OSI Systems, Inc.(米国)、Hill-Rom(Baxter)(米国)、Mindray Medical International Limited(中国)、SCHILLER AG(スイス)、Bittium(フィンランド)、フクダ電子(日本)、BPL Medical Technologies(インド)などがあります。
目次
TABLE OF CONTENTS
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.3.3 CURRENCY CONSIDERED
1.4 STUDY LIMITATIONS
1.5 MARKET STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.1.2 Objectives of secondary research
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primary interviews
2.1.2.3 Objectives of primary research
2.2 MARKET ESTIMATION METHODOLOGY
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Approach 1: Company revenue estimation approach
2.2.1.2 Approach 2: Presentations of companies and primary interviews
2.2.1.3 Growth forecast
2.2.2 TOP-DOWN APPROACH
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 DATA TRIANGULATION
2.4 STUDY ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
2.6 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 HOLTER ECG MARKET OVERVIEW
4.2 HOLTER ECG MARKET, BY PRODUCT, 2025 VS. 2030
4.3 EUROPE: HOLTER ECG MARKET, BY PRODUCT AND REGION (2024)
4.4 HOLTER ECG MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.5 HOLTER ECG MARKET: REGIONAL MIX, 2023-2030 (USD MILLION)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising geriatric population and growing focus on patient monitoring
5.2.1.2 Increasing prevalence of cardiovascular diseases
5.2.1.3 Technological advancements in wireless monitoring and wearable devices
5.2.1.4 Increasing funding investments for cardiac research monitoring
5.2.2 RESTRAINTS
5.2.2.1 Frequent product recalls
5.2.3 OPPORTUNITIES
5.2.3.1 High growth potential of emerging economies
5.2.4 CHALLENGES
5.2.4.1 Stringent regulatory requirements for product commercialization
5.2.4.2 Shortage of skilled professionals for operation of cardiac monitoring devices
5.3 REGULATORY SCENARIO
5.3.1 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
5.3.2 REGULATORY FRAMEWORK
5.3.2.1 North America
5.3.2.1.1 US
5.3.2.1.2 Canada
5.3.2.2 Europe
5.3.2.3 Asia Pacific
5.3.2.3.1 China
5.3.2.3.2 Japan
5.3.2.3.3 India
5.3.2.4 Latin America
5.3.2.4.1 Brazil
5.3.2.4.2 Mexico
5.3.2.5 Middle East
5.3.2.6 Africa
5.4 VALUE CHAIN ANALYSIS
5.4.1 RESEARCH & DEVELOPMENT
5.4.2 RAW MATERIAL PROCUREMENT & MANUFACTURING
5.4.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
5.5 SUPPLY CHAIN ANALYSIS
5.5.1 PROMINENT COMPANIES
5.5.2 SMALL & MEDIUM-SIZED ENTERPRISES
5.5.3 DISTRIBUTORS
5.5.4 END USERS
5.6 ECOSYSTEM ANALYSIS
5.7 PORTER'S FIVE FORCES ANALYSIS
5.7.1 THREAT OF NEW ENTRANTS
5.7.2 THREAT OF SUBSTITUTES
5.7.3 BARGAINING POWER OF BUYERS
5.7.4 BARGAINING POWER OF SUPPLIERS
5.7.5 INTENSITY OF COMPETITIVE RIVALRY
5.8 KEY STAKEHOLDERS & BUYING CRITERIA
5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.8.2 KEY BUYING CRITERIA
5.9 CASE STUDY ANALYSIS
5.9.1 CASE STUDY
5.9.2 CASE STUDY
5.10 TRADE ANALYSIS
5.10.1 IMPORT DATA HS CODE 901811
5.10.2 EXPORT DATA HS CODE 901811
5.11 PATENT ANALYSIS
5.11.1 LIST OF PRIMARY PATENTS
5.12 PRICING ANALYSIS
5.12.1 AVERAGE SELLING PRICE FOR WIRED HOLTER ECG MONITORS
5.12.1.1 Average selling price trend for Wired Holter ECG monitors
5.12.2 AVERAGE SELLING PRICE, BY REGION
5.12.2.1 Average selling price trend of wired Holter ECG monitors, by region
5.13 TECHNOLOGY ANALYSIS
5.13.1 KEY TECHNOLOGIES
5.13.1.1 Digital ECG recording & signal processing
5.13.1.2 Cloud-based data storage & remote monitoring
5.13.1.3 Wireless & Bluetooth connectivity
5.13.1.4 Multi-channel ECG monitoring
5.13.2 COMPLEMENTARY TECHNOLOGIES
5.13.2.1 Telemetry & real-time ECG Transmission
5.13.2.2 Patch-based & wearable ECG devices
5.13.2.3 Mobile & wearable health apps
5.13.3 ADJACENT TECHNOLOGIES
5.13.3.1 Implantable Loop Recorders (ILRS)
5.13.3.2 AI-driven predictive cardiology solutions
5.14 KEY CONFERENCES & EVENTS, 2025-2026
5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.15.1 REVENUE SHIFT & REVENUE POCKETS FOR HOLTER ECG MANUFACTURERS
5.16 INVESTMENT & FUNDING SCENARIO
5.17 UNMET NEEDS
5.18 IMPACT OF AI/GEN AI ON HOLTER ECG MARKET
5.19 IMPACT OF 2025 US TARIFF-HOLTER ECG MARKET
5.19.1 INTRODUCTION
5.19.2 KEY TARIFF RATES
5.19.3 PRICE IMPACT ANALYSIS
5.19.4 PRICE IMPACT ON COUNTRY/REGION
5.19.4.1 US
5.19.4.2 Europe
5.19.4.3 Asia Pacific
5.19.5 IMPACT ON END-USE INDUSTRIES
6 HOLTER ECG MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 WIRED HOLTER ECG MONITORS
6.2.1 CONVENTIONAL HOLTER ECG MONITORS
6.2.1.1 Continued reliability and simplicity to boost demand
6.2.2 MULTI-CHANNEL HOLTER ECG MONITORS
6.2.2.1 Enhanced diagnostic capabilities to support market penetration
6.2.3 EXTENDED HOLTER ECG MONITORS
6.2.3.1 Growing preference for long-term monitoring to enhance diagnostic accuracy
6.3 WIRELESS HOLTER ECG MONITORS
6.3.1 TELEMETRY HOLTER ECG MONITORS
6.3.1.1 Real-time data transmission and mobility to fuel market
6.3.2 WEARABLE HOLTER ECG MONITORS
6.3.2.1 Enhanced patient compliance and real-time data to boost demand
6.3.3 OTHER WIRELESS HOLTER ECG MONITORS
6.4 SOFTWARE
6.4.1 INTEGRATION OF PATIENT DATA WITH RAPID INSIGHTS TO SUPPORT MARKET GROWTH
7 HOLTER ECG MARKET, BY LEAD TYPE
7.1 INTRODUCTION
7.2 PATCH TYPE 1-LEAD HOLTER MONITORS
7.2.1 ABILITY TO OFFER RAPID RESULTS TO DRIVE MARKET
7.3 3-LEAD HOLTER MONITORS
7.3.1 ABILITY TO PERFORM MULTIPLE DIAGNOSTIC TESTS SIMULTANEOUSLY TO BOOST DEMAND
7.4 6-LEAD HOLTER MONITORS
7.4.1 WIDE APPLICATIONS ACROSS REMOTE PATIENT MONITORING TO BOOST DEMAND
7.5 12-LEAD HOLTER MONITORS
7.5.1 UTILIZATION ACROSS HOSPITALS & CLINIC SETTINGS TO PROPEL MARKET
7.6 OTHER LEAD TYPES
8 HOLTER ECG MARKET, BY END USER
8.1 INTRODUCTION
8.2 HOSPITALS AND SPECIALTY CLINICS
8.2.1 INCREASING ESTABLISHMENT OF CARDIAC CENTERS TO DRIVE MARKET
8.3 AMBULATORY SURGERY CENTERS
8.3.1 LOW-COST PROCEDURES WITH HIGH CONVENIENCE TO BOOST DEMAND
8.4 OTHER END USERS
9 HOLTER ECG MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
9.2.2 US
9.2.2.1 High healthcare expenditure to drive market
9.2.3 CANADA
9.2.3.1 Rising prevalence of lifestyle diseases to boost demand
9.3 EUROPE
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
9.3.2 GERMANY
9.3.2.1 Favorable government policies for advanced cardiac treatments to fuel uptake
9.3.3 UK
9.3.3.1 Increasing demand for home-based cardiac monitoring devices to support market growth
9.3.4 FRANCE
9.3.4.1 Rising incidence of CVD and stroke to propel market
9.3.5 ITALY
9.3.5.1 Rising cases of obesity and CVD to boost demand
9.3.6 SPAIN
9.3.6.1 Growing focus on cardiac monitoring to fuel market
9.3.7 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
9.4.2 CHINA
9.4.2.1 Increasing public access to modern healthcare to aid market
9.4.3 JAPAN
9.4.3.1 Favorable regulatory framework for product commercialization to drive market
9.4.4 INDIA
9.4.4.1 Favorable healthcare investments to support market growth
9.4.5 AUSTRALIA
9.4.5.1 Supportive healthcare initiatives for advanced care to fuel market
9.4.6 THAILAND
9.4.6.1 Rising demand for advanced healthcare diagnostics to fuel market
9.4.7 SINGAPORE
9.4.7.1 Establishment of advanced healthcare facilities to fuel market
9.4.8 INDONESIA
9.4.8.1 Collaborations among medical device companies to boost market
9.4.9 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
9.5.2 BRAZIL
9.5.2.1 Increasing prevalence of CVD to drive market
9.5.3 MEXICO
9.5.3.1 Expansion of leading market players for innovative products to support market growth
9.5.4 REST OF LATIN AMERICA
9.6 MIDDLE EAST & AFRICA
9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
9.6.2 GCC COUNTRIES
9.6.2.1 Increasing rates for medical tourism to drive market
9.6.3 REST OF MIDDLE EAST & AFRICA
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN HOLTER ECG MARKET
10.3 REVENUE ANALYSIS, 2020-2024
10.4 MARKET SHARE ANALYSIS, 2024
10.4.1 RANKING OF KEY MARKET PLAYERS
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
10.5.5.1 Company footprint
10.5.5.2 Region footprint
10.5.5.3 Product footprint
10.5.5.4 Lead type footprint
10.5.5.5 End-user footprint
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
10.6.1 PROGRESSIVE COMPANIES
10.6.2 RESPONSIVE COMPANIES
10.6.3 DYNAMIC COMPANIES
10.6.4 STARTING BLOCKS
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
10.6.5.1 Detailed list of key startup/SME players
10.6.5.2 Competitive benchmarking of key emerging players/startups
10.7 VALUATION & FINANCIAL METRICS
10.7.1 FINANCIAL METRICS
10.7.2 COMPANY VALUATION
10.8 BRAND/PRODUCT COMPARISON
10.9 COMPETITIVE SCENARIO
10.9.1 PRODUCT LAUNCHES
10.9.2 DEALS
10.9.3 EXPANSIONS
10.9.4 OTHER DEVELOPMENTS
11 COMPANY PROFILES
11.1 KEY PLAYERS
11.1.1 GE HEALTHCARE TECHNOLOGIES INC.
11.1.1.1 Business overview
11.1.1.2 Products offered
11.1.1.3 Recent developments
11.1.1.3.1 Deals
11.1.1.4 MnM view
11.1.1.4.1 Key strengths
11.1.1.4.2 Strategic choices
11.1.1.4.3 Weaknesses & competitive threats
11.1.2 KONINKLIJKE PHILIPS N.V.
11.1.2.1 Business overview
11.1.2.2 Products offered
11.1.2.3 Recent developments
11.1.2.3.1 Product launches & approvals
11.1.2.3.2 Deals
11.1.2.3.3 Expansions
11.1.2.3.4 Other developments
11.1.2.4 MnM view
11.1.2.4.1 Key strengths
11.1.2.4.2 Strategic choices
11.1.2.4.3 Weaknesses & competitive threats
11.1.3 NIHON KOHDEN CORPORATION
11.1.3.1 Business overview
11.1.3.2 Products offered
11.1.3.3 MnM view
11.1.3.3.1 Key strengths
11.1.3.3.2 Strategic choices
11.1.3.3.3 Weaknesses & competitive threats
11.1.4 OSI SYSTEMS, INC.
11.1.4.1 Business overview
11.1.4.2 Products offered
11.1.4.3 Recent developments
11.1.4.3.1 Product launches
11.1.4.4 MnM view
11.1.4.4.1 Key strengths
11.1.4.4.2 Strategic choices
11.1.4.4.3 Weaknesses & competitive threats
11.1.5 HILLROM (BAXTER INTERNATIONAL INC.)
11.1.5.1 Business overview
11.1.5.2 Products offered
11.1.5.3 MnM view
11.1.5.3.1 Key strengths
11.1.5.3.2 Strategic choices
11.1.5.3.3 Weaknesses & competitive threats
11.1.6 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
11.1.6.1 Business overview
11.1.6.2 Products offered
11.1.6.3 Recent developments
11.1.6.3.1 Deals
11.1.7 SCHILLER AG
11.1.7.1 Business overview
11.1.7.2 Products offered
11.1.7.3 Recent developments
11.1.7.3.1 Product launches
11.1.8 BITTIUM
11.1.8.1 Business overview
11.1.8.2 Products offered
11.1.9 FUKUDA DENSHI CO., LTD.
11.1.9.1 Business overview
11.1.9.2 Products offered
11.1.10 BPL MEDICAL TECHNOLOGIES PVT. LTD.
11.1.10.1 Business overview
11.1.10.2 Products offered
11.1.10.3 Recent developments
11.1.10.3.1 Expansions
11.1.11 CARDIOLINE
11.1.11.1 Business overview
11.1.11.2 Products offered
11.1.11.3 Recent developments
11.1.11.3.1 Product launches & approvals
11.2 OTHER PLAYERS
11.2.1 QINGDAO MEDITECH EQUIPMENT CO., LTD (MEDITECH GROUP)
11.2.2 EDAN INSTRUMENTS, INC.
11.2.3 MIDMARK CORPORATION
11.2.4 CARDIOCOMM SOLUTIONS, INC.
11.2.5 VITALCONNECT
11.2.6 BORSAM BIOMEDICAL INSTRUMENTS CO., LTD.
11.2.7 NASIFF ASSOCIATES INC.
11.2.8 VECTRACOR
11.2.9 SCOTTCARE
11.2.10 BIOMEDICAL INSTRUMENTS CO., LTD.
11.2.11 EB NEURO S.P.A.
11.2.12 VIATOM TECHNOLOGY CO., LTD.
11.2.13 BIOTRICITY
11.2.14 NASAN MEDICAL ELECTRONICS PVT. LTD.
11.2.15 LIFESIGNALS
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
